§ Funding Round
Series C funding round for Prellis Biologics raising $35M in August 2022
Series C funding round for Prellis Biologics raising $35M in August 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Buckley Ventures | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Saga | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | alexander gerko | |
| Angel | louis beryl | |
| Angel | martin añazco | |
| Angel | matt bellamy | |
| Angel | mattia astori | |
| Angel | Michael Moritz | |
| Angel | Paul Graham | |
| Angel | sahin boydas | |
| Angel | Sam Altman | |
| Angel | sue xu | |
lei mengLEAD | Angel | lei meng |
michael marksLEAD | Angel | michael marks |
| Organization | — | |
| Organization | — |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$83.1M
Top Valuation
-
Prellis Biologics raised $35M in a Series C round.
The round was announced on 08/01/22.
The round was led by lei meng, michael marks.
